News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Jonathan Lapin, PharmD

Advertisement

Articles by Jonathan Lapin, PharmD

Role of Immunosuppression on Community-Acquired Clostridioides difficile Risk

ByJonathan Lapin, PharmD
October 13th 2021

CDI remains an urgent public health threat and continues to be the most frequent cause of diarrhea among hospitalized patients and overall hospital-acquired infection in the United States.

Double Trouble: Assessing the Impact of Combining Daptomycin and Fosfomycin for MRSA Bacteremia

ByJonathan Lapin, PharmD,Tiffany Lee, PharmD, BCIDP
September 18th 2020

This highlighted study looks at using these 2 therapies concurrently for this infection.

Advertisement

Latest Updated Articles

  • Double Trouble: Assessing the Impact of Combining Daptomycin and Fosfomycin for MRSA Bacteremia
    Double Trouble: Assessing the Impact of Combining Daptomycin and Fosfomycin for MRSA Bacteremia

    Published: September 18th 2020 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Infectious Disease Regulatory Watch: December Highlights

2

Protectors vs Police: How Antimicrobial Stewardship Interventions Come Across and How to Change the Narrative

3

Phase 3 Clinical Trial Reporting, Prospective Regulatory Filings to Watch For in 2026

4

"Moderate" Evidence Supports Latest Pentavalent Meningococcal Vaccine as Alternative to Separate Quadrivalent and MenB

5

A Therapeutic Challenge: Quadruple-Valve Endocarditis Resulting From Injection Drug Use

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us